Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cerebrovascular Reserve and White Matter Disease in Patients With Chronic Anemia

Trial Profile

Cerebrovascular Reserve and White Matter Disease in Patients With Chronic Anemia

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Jan 2019

At a glance

  • Drugs Hydroxycarbamide (Primary)
  • Indications Sickle cell anaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top